Target intelligence / Profile preview

Zinc transporter ZIP2 (ZIP2)

Target
ZIP2
Molecular classification
Transporter, SLC (solute carrier) family, ZIP (Zrt-/Irt-like protein) family, integral membrane protein
01

Overview

Zinc transporter ZIP2 (SLC39A2) is a member of the solute carrier family 39 of membrane transporters, specifically the ZIP (Zrt/Irt-like protein) family, responsible for mediating the cellular uptake of zinc and other divalent metal ions from the extracellular environment into the cytoplasm[1][2][3]. SLC39A2 is predicted to have eight transmembrane domains with both termini facing the extracellular side[1][2]. It is widely expressed, with notably high expression in prostate and uterine epithelial cells[2]. ZIP2 primarily transports zinc (Zn²⁺), but can also transport cadmium (Cd²⁺), copper (Cu²⁺), and cobalt (Co²⁺), in order of decreasing affinity; it does not transport iron (Fe²⁺)[2][3]. Transport activity is modulated by extracellular pH and membrane potential, but is independent of ATP and sodium or potassium gradients[1][3][4]. Mutations in SLC39A2 are associated with susceptibility to carotid artery disease, and ZIP2 plays a role in epidermal keratinocyte differentiation[3]. ZIP2's biological relevance is tied to maintaining proper cellular zinc levels, essential for numerous cellular processes and enzymatic activities[1][2].

Other names
SLC39A2ZIP-2hZIP26A1Eti-1Solute carrier family 39 member 2Zrt- and Irt-like protein 2zinc transporter 2ZRT/IRT-like protein 2zinc uptake transporter 2ETI-1
02

Mechanism of action

Modulation of zinc influx and intracellular zinc homeostasis; Divalent cation symport (Zn²⁺, Cd²⁺, Cu²⁺, Co²⁺); Electrochemical modulation and pH-dependent transport[1][4]

03

Biological functions

Zinc uptake/transport into the cytoplasmTransport of other divalent metal cations (Cd²⁺, Cu²⁺, Co²⁺, less so Mn²⁺)Metal ion homeostasisKeratinocyte differentiation (in skin)[3]
04

Disease associations

Carotid artery disease[3]Possibly cancer (based on tissue expression and metal dysregulation)Other diseases associated with trace metal homeostasis
05

Safety considerations

Disruption could affect systemic zinc homeostasis and cause trace metal imbalance[1][2]Non-selective transport of toxic metals (e.g., cadmium) could be a concern if modulated pharmacologically[1]
06

Biomarkers

ZIP2 protein expression may be a research-level biomarker in prostate and uterine tissues, but not a validated clinical biomarker

Beyond the preview

Go deeper on Zinc transporter ZIP2 (ZIP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc transporter ZIP2 (ZIP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call